Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
Cancer immunotherapy has emerged as a mainstream therapy option in the battle against cancer. Pre-clinical data demonstrates the ability of immunotherapy to harness the immune system to fight disseminated malignancy. Clinical translation has failed to recapitulate the promising results of pre-clin...
Main Authors: | Arta Monir Monjazeb, Anthony E Zamora, Steven K Grossenbacher, Annie eMirsoian, Gail D Sckisel, William J Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00197/full |
Similar Items
-
Immunoediting-induced Immunotherapy Resistance
by: LYU LYU, et al.
Published: (2020-04-01) -
Adaptive resistance to immunotherapy directed against p53 can be overcome by global expression of tumor antigens in dendritic cells
by: Matjaz eHumar, et al.
Published: (2014-10-01) -
Editorial: Radiation and the Immune System: Current Knowledge and Future Perspectives
by: Katalin Lumniczky, et al.
Published: (2018-01-01) -
Cancer Immunotherapy and Next-Generation Clinical Immune Assessment
by: Chao eMa, et al.
Published: (2014-09-01) -
IMMUNE RESPONSE IN MALIGNANT GLIOMA
by: Iliyan Koev, et al.
Published: (2010-07-01)